Foamix Pharmaceuticals appoints Dr Aaron Schwartz to its Board of Directors

– USA, NJ / ISRAEL, Rehovot – Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, today announced that it has appointed Dr.…